These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27766589)

  • 1. Assessment of Distal Radius Bone Mineral Density in Osteoporosis Patients Receiving Denosumab, Including Those with Rheumatoid Arthritis and Those Receiving Oral Glucocorticoids.
    Matsuno H
    Drugs R D; 2016 Dec; 16(4):347-353. PubMed ID: 27766589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denosumab significantly improves bone mineral density with or without bisphosphonate pre-treatment in osteoporosis with rheumatoid arthritis : Denosumab improves bone mineral density in osteoporosis with rheumatoid arthritis.
    Nakamura Y; Suzuki T; Kato H
    Arch Osteoporos; 2017 Sep; 12(1):80. PubMed ID: 28936606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis.
    Ebina K; Hirao M; Hashimoto J; Hagihara K; Kashii M; Kitaguchi K; Matsuoka H; Iwahashi T; Chijimatsu R; Yoshikawa H
    J Bone Miner Metab; 2018 Jul; 36(4):478-487. PubMed ID: 28766140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates.
    Dore RK; Cohen SB; Lane NE; Palmer W; Shergy W; Zhou L; Wang H; Tsuji W; Newmark R;
    Ann Rheum Dis; 2010 May; 69(5):872-5. PubMed ID: 19734132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of denosumab and bisphosphonates for treating secondary osteoporosis in patients with rheumatoid arthritis.
    Kinoshita H; Miyakoshi N; Kashiwagura T; Kasukawa Y; Sugimura Y; Shimada Y
    Mod Rheumatol; 2017 Jul; 27(4):582-586. PubMed ID: 27659808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year results of denosumab treatment for osteoporosis in women with rheumatoid arthritis and primary osteoporosis: A clinical observational study.
    Mochizuki T; Yano K; Ikari K; Hiroshima R; Nasu Y; Okazaki K
    Mod Rheumatol; 2021 May; 31(3):600-606. PubMed ID: 32815449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis.
    Nakamura Y; Suzuki T; Yoshida T; Yamazaki H; Kato H
    Nutrients; 2017 Apr; 9(5):. PubMed ID: 28445420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients.
    Deodhar A; Dore RK; Mandel D; Schechtman J; Shergy W; Trapp R; Ory PA; Peterfy CG; Fuerst T; Wang H; Zhou L; Tsuji W; Newmark R
    Arthritis Care Res (Hoboken); 2010 Apr; 62(4):569-74. PubMed ID: 20391513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis.
    Ebina K; Hirao M; Hashimoto J; Matsuoka H; Iwahashi T; Chijimatsu R; Etani Y; Okamura G; Miyama A; Yoshikawa H
    Osteoporos Int; 2018 Jul; 29(7):1627-1636. PubMed ID: 29574517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of serum bone-related minerals during denosumab treatment in osteoporosis patients with rheumatoid arthritis: Mineral change by denosumab in osteoporosis with rheumatoid arthritis.
    Suzuki T; Nakamura Y; Kato H
    Clin Nutr ESPEN; 2018 Aug; 26():53-56. PubMed ID: 29908683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Denosumab is effective toward glucocorticoid-induced osteoporosis patients complicated with rheumatic diseases regardless of prior anti-osteoporotic drugs.
    Iwamoto N; Okamoto M; Tsuji S; Endo Y; Takatani A; Shimizu T; Umeda M; Fukui S; Sumiyoshi R; Igawa T; Koga T; Kawashiri SY; Aramaki T; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Ueki Y; Kawakami A
    J Bone Miner Metab; 2019 May; 37(3):554-562. PubMed ID: 30187273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denosumab or oral bisphosphonates in primary osteoporosis: a "real-life" study.
    Cairoli E; Palmieri S; Goggi G; Roggero L; Arosio M; Chiodini I; Eller-Vainicher C
    J Endocrinol Invest; 2018 Aug; 41(8):1005-1013. PubMed ID: 29340971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids.
    Sawamura M; Komatsuda A; Togashi M; Wakui H; Takahashi N
    Intern Med; 2017; 56(6):631-636. PubMed ID: 28321061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid.
    Okano T; Koike T; Tada M; Sugioka Y; Mamoto K; Wakitani S; Nakamura H
    J Bone Miner Metab; 2014 Sep; 32(5):593-600. PubMed ID: 24233123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial.
    Mok CC; Ho LY; Ma KM
    Bone; 2015 Jun; 75():222-8. PubMed ID: 25761434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
    Korczowska I; Olewicz-Gawlik A; Trefler J; Hrycaj P; Krzysztof Łacki J
    Clin Rheumatol; 2008 May; 27(5):565-72. PubMed ID: 17909741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of denosumab efficacy in treating osteoporosis in patients with rheumatoid arthritis: a Japanese multicenter study.
    Hattori K; Hirano Y; Kanayama Y; Takahashi N; Ishiguro N; Kojima T
    Nagoya J Med Sci; 2019 Nov; 81(4):571-585. PubMed ID: 31849375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab improves bone mineral density and microarchitecture in rheumatoid arthritis: randomized controlled trial by HR-pQCT.
    Chiba K; Iwamoto N; Watanabe K; Shiraishi K; Saito K; Okubo N; Kawakami A; Osaki M
    J Bone Miner Metab; 2023 Nov; 41(6):797-806. PubMed ID: 37480398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparable efficacy of denosumab on bone mineral density in rheumatoid arthritis patients with postmenopausal osteoporosis: A retrospective case-control study.
    Kim SK; Kim JW; Lee H; Park SH; Choe JY; Kim B
    Medicine (Baltimore); 2023 Jun; 102(26):e34219. PubMed ID: 37390268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.